Literature DB >> 33572732

Acute Clinical Syndromes and Suspicion of SARS-CoV-2 Infection: The Experience of a Single Romanian Center in the Early Pandemic Period.

Raluca Ecaterina Haliga1,2, Victorita Sorodoc1,2, Catalina Lionte1,2, Ovidiu Rusalim Petris1,2, Cristina Bologa1,2, Adorata Elena Coman1,2, Luminita Gina Vata1,2, Gabriela Puha1,2, Gabriela Dumitrescu1,2, Oana Sirbu1,2, Alexandra Stoica1,2, Alexandr Ceasovschih1,2, Mihai Constantin1,2, Andreea Nicoleta Catana3, Elisabeta Jaba4, Laurentiu Sorodoc1,2.   

Abstract

Background and
Objectives: During the coronavirus disease 2019 (COVID-19) pandemic, patients with chronic diseases suffering exacerbations have required acute medical care. The purpose of our study was to determine useful criteria for the differentiation of patients with acute clinical syndromes and suspicion of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Materials and
Methods: This was an observational retrospective study, conducted in an internal medicine clinic from April to May 2020. We collected clinical, biological, and computed tomography (CT) data on patients with exacerbations of chronic diseases and clinical suspicion of SARS-CoV-2 infection. Patients with an already-positive real-time reverse-transcription polymerase chain reaction (RT-PCR) test for SARS-CoV-2 on presentation at the emergency department were excluded from our study.
Results: Of 253 suspected cases, 20 were laboratory-confirmed as having SARS-CoV-2 infection by RT-PCR, whereas COVID-19 diagnosis was ruled out in the remaining 233. Venous thromboembolism (VTE) correlated significantly with COVID-19 diagnosis in suspected patients, while laboratory markers were not significantly different between the two groups. Of the suspected patients, significantly higher percentages of dry cough, fever, myalgias, sore throat, loss of smell and appetite, and ground-glass opacities (GGOs) on CT were found in SARS-CoV-2-positive individuals. Conclusions: The study demonstrated that, until receiving the result of an RT-PCR test for SARS-CoV-2 (usually 12-24 h), association with VTE as a comorbidity, fever, dry cough, and myalgia as clinical features, and GGO on CT are the main markers for the identification of COVID-19 patients among those suspected with acute clinical syndromes. Our results also provide evidence for doctors not to rely solely on biological markers in the case of suspected SARS-CoV-2 infection in patients with exacerbations of chronic diseases. These data are useful for faster decision-making with regard to suspected COVID-19 patients before receiving RT-PCR test results, thus avoiding keeping patients in crowded emergency departments.

Entities:  

Keywords:  acute clinical syndromes; differential diagnosis; suspicion of SARS-CoV-2 infection

Mesh:

Year:  2021        PMID: 33572732      PMCID: PMC7911742          DOI: 10.3390/medicina57020121

Source DB:  PubMed          Journal:  Medicina (Kaunas)        ISSN: 1010-660X            Impact factor:   2.430


  29 in total

1.  D-dimer level for predicting the in-hospital mortality in liver cirrhosis: A retrospective study.

Authors:  Yun Li; Xingshun Qi; Hongyu Li; Junna Dai; Han Deng; Jing Li; Ying Peng; Xu Liu; Xiaolin Sun; Xiaozhong Guo
Journal:  Exp Ther Med       Date:  2016-11-28       Impact factor: 2.447

2.  Systemic inflammation up-regulates serum hepcidin in exacerbations and stabile chronic obstructive pulmonary disease.

Authors:  Leida Tandara; Tihana Zanic Grubisic; Gudelj Ivan; Zrinka Jurisic; Marijan Tandara; Katarina Gugo; Suzana Mladinov; Ilza Salamunic
Journal:  Clin Biochem       Date:  2015-07-09       Impact factor: 3.281

3.  The expressions and significance of APN, D-D, IL-17 and hs-CRP in patients with acute exacerbation of chronic obstructive pulmonary disease.

Authors:  G-Z Ding; W-S Li
Journal:  Eur Rev Med Pharmacol Sci       Date:  2018-10       Impact factor: 3.507

4.  High serum ferritin is associated with worse outcome of patients with decompensated cirrhosis.

Authors:  Theodora Oikonomou; Ioannis Goulis; Stergios Soulaidopoulos; Areti Karasmani; Petros Doumtsis; Konstantina Tsioni; Eudokia Mandala; Evangelos Akriviadis; Evangelos Cholongitas
Journal:  Ann Gastroenterol       Date:  2016-12-08

5.  Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.

Authors:  Chaolin Huang; Yeming Wang; Xingwang Li; Lili Ren; Jianping Zhao; Yi Hu; Li Zhang; Guohui Fan; Jiuyang Xu; Xiaoying Gu; Zhenshun Cheng; Ting Yu; Jiaan Xia; Yuan Wei; Wenjuan Wu; Xuelei Xie; Wen Yin; Hui Li; Min Liu; Yan Xiao; Hong Gao; Li Guo; Jungang Xie; Guangfa Wang; Rongmeng Jiang; Zhancheng Gao; Qi Jin; Jianwei Wang; Bin Cao
Journal:  Lancet       Date:  2020-01-24       Impact factor: 79.321

Review 6.  COVID-19 diagnosis and management: a comprehensive review.

Authors:  Giuseppe Pascarella; Alessandro Strumia; Chiara Piliego; Federica Bruno; Romualdo Del Buono; Fabio Costa; Simone Scarlata; Felice Eugenio Agrò
Journal:  J Intern Med       Date:  2020-05-13       Impact factor: 13.068

7.  Chest CT Features of COVID-19 in Rome, Italy.

Authors:  Damiano Caruso; Marta Zerunian; Michela Polici; Francesco Pucciarelli; Tiziano Polidori; Carlotta Rucci; Gisella Guido; Benedetta Bracci; Chiara De Dominicis; Andrea Laghi
Journal:  Radiology       Date:  2020-04-03       Impact factor: 11.105

8.  Autopsy Findings and Venous Thromboembolism in Patients With COVID-19: A Prospective Cohort Study.

Authors:  Dominic Wichmann; Jan-Peter Sperhake; Marc Lütgehetmann; Stefan Steurer; Carolin Edler; Axel Heinemann; Fabian Heinrich; Herbert Mushumba; Inga Kniep; Ann Sophie Schröder; Christoph Burdelski; Geraldine de Heer; Axel Nierhaus; Daniel Frings; Susanne Pfefferle; Heinrich Becker; Hanns Bredereke-Wiedling; Andreas de Weerth; Hans-Richard Paschen; Sara Sheikhzadeh-Eggers; Axel Stang; Stefan Schmiedel; Carsten Bokemeyer; Marylyn M Addo; Martin Aepfelbacher; Klaus Püschel; Stefan Kluge
Journal:  Ann Intern Med       Date:  2020-05-06       Impact factor: 25.391

9.  Incidence of thrombotic complications in critically ill ICU patients with COVID-19.

Authors:  F A Klok; M J H A Kruip; N J M van der Meer; M S Arbous; D A M P J Gommers; K M Kant; F H J Kaptein; J van Paassen; M A M Stals; M V Huisman; H Endeman
Journal:  Thromb Res       Date:  2020-04-10       Impact factor: 3.944

10.  Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention.

Authors:  Zunyou Wu; Jennifer M McGoogan
Journal:  JAMA       Date:  2020-04-07       Impact factor: 56.272

View more
  2 in total

Review 1.  Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Authors:  Thomas Struyf; Jonathan J Deeks; Jacqueline Dinnes; Yemisi Takwoingi; Clare Davenport; Mariska Mg Leeflang; René Spijker; Lotty Hooft; Devy Emperador; Julie Domen; Anouk Tans; Stéphanie Janssens; Dakshitha Wickramasinghe; Viktor Lannoy; Sebastiaan R A Horn; Ann Van den Bruel
Journal:  Cochrane Database Syst Rev       Date:  2022-05-20

2.  The Utility of Laboratory Parameters for Cardiac Inflammation in Heart Failure Patients Hospitalized with SARS-CoV-2 Infection.

Authors:  Ciprian Nicolae Pilut; Cosmin Citu; Florin Gorun; Felix Bratosin; Oana Maria Gorun; Bogdan Burlea; Ioana Mihaela Citu; Mirela Loredana Grigoras; Diana Manolescu; Adrian Gluhovschi
Journal:  Diagnostics (Basel)       Date:  2022-03-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.